Eton Pharmaceuticals (ETON) Short Interest Ratio & Short Volume → Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad) Free ETON Stock Alerts $3.63 +0.08 (+2.25%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Eton Pharmaceuticals Short Interest DataCurrent Short Volume87,400 sharesPrevious Short Volume148,100 sharesChange Vs. Previous Month-40.99%Dollar Volume Sold Short$305,900.00Short Interest Ratio / Days to Cover1.5Last Record DateApril 30, 2024Outstanding Shares25,691,000 sharesFloat Size24,410,000 sharesShort Percent of Float0.36%Today's Trading Volume83,035 sharesAverage Trading Volume66,700 sharesToday's Volume Vs. Average124% Short Selling Eton Pharmaceuticals ? Sign up to receive the latest short interest report for Eton Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatETON Short Interest Over TimeETON Days to Cover Over TimeETON Percentage of Float Shorted Over Time Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Eton Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202487,400 shares $305,900.00 -41.0%0.4%1.5 $3.50 4/15/2024148,100 shares $476,882.00 -32.8%0.7%2.4 $3.22 3/31/2024220,400 shares $826,500.00 -9.3%1.0%3.1 $3.75 3/15/2024242,900 shares $935,165.00 +6.9%1.1%3.2 $3.85 2/29/2024227,200 shares $1.01 million -38.0%1.0%3.2 $4.45 2/15/2024366,200 shares $1.68 million -4.6%1.6%5.3 $4.59 Get the Latest News and Ratings for ETON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eton Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024384,000 shares $1.79 million +0.7%1.7%4.6 $4.67 1/15/2024381,200 shares $1.67 million -14.5%1.7%4.5 $4.37 12/31/2023445,800 shares $1.95 million +22.5%2.0%5.1 $4.38 12/15/2023363,800 shares $1.62 million -41.4%1.6%3.8 $4.45 11/30/2023620,900 shares $2.20 million -17.6%2.8%4.9 $3.54 11/15/2023753,600 shares $2.78 million -21.1%3.4%4.7 $3.69 10/31/2023954,600 shares $4.03 million -5.5%4.3%2.1 $4.22 10/15/20231,010,000 shares $3.96 million +3.0%4.5%2.2 $3.92 9/30/2023980,700 shares $4.09 million +3.6%4.4%2.1 $4.17 9/15/2023946,700 shares $4.69 million -1.2%4.2%2.1 $4.95 8/31/2023958,600 shares $4.31 million -27.4%4.3%2.3 $4.50 8/15/20231,320,000 shares $6.26 million +150.1%5.9%3.5 $4.74 7/31/2023527,700 shares $1.49 million -6.2%2.4%9.6 $2.82 7/15/2023562,700 shares $1.67 million +3.8%2.5%11.5 $2.97 6/30/2023542,100 shares $1.89 million -1.8%2.4%11.8 $3.49 6/15/2023552,000 shares $2.02 million -1.9%2.5%12 $3.66 5/31/2023562,700 shares $2.23 million +6.1%2.5%11.4 $3.96 5/15/2023530,400 shares $1.88 million -9.7%2.4%11.1 $3.54 4/30/2023587,500 shares $2.13 million +7.4%2.7%12.1 $3.63 4/15/2023547,200 shares $1.93 million +6.9%2.5%9.4 $3.52 3/31/2023511,700 shares $1.97 million -1.3%2.3%7.7 $3.85 3/15/2023518,300 shares $1.97 million +11.0%2.4%7.7 $3.80 2/28/2023467,100 shares $1.74 million +5.5%2.1%7.2 $3.73 2/15/2023442,600 shares $1.54 million -5.8%2.0%6.6 $3.49 1/31/2023469,900 shares $1.64 million -14.1%2.1%6.3 $3.48 1/15/2023547,100 shares $1.91 million -10.9%2.5%7 $3.50 12/30/2022614,100 shares $1.73 million +16.0%2.8%8.9 $2.82 12/15/2022529,200 shares $1.72 million -6.4%2.4%7.4 $3.25 11/30/2022565,500 shares $1.71 million -13.7%2.6%8.8 $3.02 11/15/2022655,000 shares $2.01 million -1.4%3.0%10.1 $3.07 10/31/2022664,000 shares $1.69 million +1.2%3.0%9 $2.55 10/15/2022655,900 shares $1.43 million -6.5%3.0%9.9 $2.18 9/30/2022701,400 shares $1.47 million -1.6%3.2%3.9 $2.10 9/15/2022712,500 shares $1.56 million -1.7%3.2%3.7 $2.19Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. ETON Short Interest - Frequently Asked Questions What is Eton Pharmaceuticals' current short interest? Short interest is the volume of Eton Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 87,400 shares of ETON short. 0.36% of Eton Pharmaceuticals' shares are currently sold short. Learn More on Eton Pharmaceuticals' current short interest. What is a good short interest ratio for Eton Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ETON shares currently have a short interest ratio of 2.0. Learn More on Eton Pharmaceuticals's short interest ratio. What is a good short interest percentage for Eton Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of Eton Pharmaceuticals' floating shares are currently sold short. Is Eton Pharmaceuticals' short interest increasing or decreasing? Eton Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 87,400 shares, a drop of 41.0% from the previous total of 148,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eton Pharmaceuticals' float size? Eton Pharmaceuticals currently has issued a total of 25,691,000 shares. Some of Eton Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eton Pharmaceuticals currently has a public float of 24,410,000 shares. How does Eton Pharmaceuticals' short interest compare to its competitors? 0.36% of Eton Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Eton Pharmaceuticals: Clearside Biomedical, Inc. (0.45%), Aclaris Therapeutics, Inc. (8.35%), Oramed Pharmaceuticals Inc. (0.80%), Anixa Biosciences, Inc. (2.08%), Milestone Pharmaceuticals Inc. (0.81%), Adagene Inc. (0.04%), BeyondSpring Inc. (9.99%), ProPhase Labs, Inc. (1.88%), Oncolytics Biotech Inc. (1.14%), IO Biotech, Inc. (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Eton Pharmaceuticals stock? Short selling ETON is an investing strategy that aims to generate trading profit from Eton Pharmaceuticals as its price is falling. ETON shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eton Pharmaceuticals? A short squeeze for Eton Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ETON, which in turn drives the price of the stock up even further. How often is Eton Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETON, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Clearside Biomedical Short Interest Aclaris Therapeutics Short Interest Oramed Pharmaceuticals Short Interest Anixa Biosciences Short Interest Milestone Pharmaceuticals Short Interest Adagene Short Interest BeyondSpring Short Interest ProPhase Labs Short Interest Oncolytics Biotech Short Interest IO Biotech Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ETON) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsHow to Make 100X on the AI BoomInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsAmerica’s worst nightmare?Porter & CompanyInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press